Michael A. Martorelli is a director at Fairmount Partners. He came to Fairmount after serving as managing director of research and senior health care analyst at Investec Inc. and its predecessor, PMG Capital. Prior to PMG Capital, Mike spent more than ten years at Janney Montgomery Scott as a research analyst covering companies in various segments of the health care industry.
In addition to participating in Fairmount’s healthcare industry investment banking activities, Mike contributes to the firm’s marketing and business development efforts with periodic industry reports and conference presentations. For most of the past two decades he has focused his writing and speaking efforts on pharmaceutical services companies, including those providing tools and technologies used in pre-clinical and clinical research functions. He has participated in conferences and similar programs covering various outsourcing topics and sponsored by the Drug Information Association (DIA), the Tufts Center for the Study of Drug Development (CSDD), and other organizations. In addition to speaking, he has written for publications such as Contract Pharma, European Pharmaceutical Contractor, Clinical Research and Regulatory Affairs, and others. He recently authored a chapter in Re-Inventing Drug Development, published by the CRC Press imprint of Taylor & Francis Group.
Michael Martorelli received his M.B.A. and his B.S. in business administration from Drexel University. For the past several years he has been an adjunct instructor and/or guest lecturer at Drexel, Philadelphia University and several other colleges in the Philadelphia area. He is a Chartered Financial Analyst (CFA) and a member of both the CFA Institute and the CFA Society of Philadelphia.